Diet Quality and Diabetes Risk in Overweight and Obese Adults
Launched by ANKARA YILDIRIM BEYAZIT UNIVERSITY · Sep 24, 2024
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Body mass index (BMI) ≥25 kg/m²
- Exclusion Criteria:
- • Diabetes mellitus
- • Psychiatric disorders
- • Pregnant and lactating
About Ankara Yildirim Beyazıt University
Ankara Yıldırım Beyazıt University is a leading academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in healthcare and innovative research methodologies to conduct ethical and scientifically rigorous clinical studies. By fostering collaboration among multidisciplinary teams, Ankara Yıldırım Beyazıt University aims to contribute to the development of novel therapies and enhance patient care, while adhering to the highest standards of regulatory compliance and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, çubuk, Turkey
Ankara, , Turkey
Patients applied
Trial Officials
Rahime E Karakaya, PhD
Principal Investigator
Ankara Yildirim Beyazıt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported